CN113080347A - 一种用于改善人体消化系统的本草饮料及其制作方式 - Google Patents
一种用于改善人体消化系统的本草饮料及其制作方式 Download PDFInfo
- Publication number
- CN113080347A CN113080347A CN202110383658.5A CN202110383658A CN113080347A CN 113080347 A CN113080347 A CN 113080347A CN 202110383658 A CN202110383658 A CN 202110383658A CN 113080347 A CN113080347 A CN 113080347A
- Authority
- CN
- China
- Prior art keywords
- parts
- fructus
- semen
- hawthorn
- beverage
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 235000013361 beverage Nutrition 0.000 title claims abstract description 29
- 210000002249 digestive system Anatomy 0.000 title claims abstract description 13
- 238000002360 preparation method Methods 0.000 title abstract description 9
- 210000000582 semen Anatomy 0.000 claims abstract description 43
- 235000009917 Crataegus X brevipes Nutrition 0.000 claims abstract description 29
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 claims abstract description 29
- 235000009685 Crataegus X maligna Nutrition 0.000 claims abstract description 29
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 claims abstract description 29
- 235000009486 Crataegus bullatus Nutrition 0.000 claims abstract description 29
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 claims abstract description 29
- 235000009682 Crataegus limnophila Nutrition 0.000 claims abstract description 29
- 240000000171 Crataegus monogyna Species 0.000 claims abstract description 29
- 235000004423 Crataegus monogyna Nutrition 0.000 claims abstract description 29
- 235000002313 Crataegus paludosa Nutrition 0.000 claims abstract description 29
- 235000009840 Crataegus x incaedua Nutrition 0.000 claims abstract description 29
- 239000003814 drug Substances 0.000 claims abstract description 27
- 244000197580 Poria cocos Species 0.000 claims abstract description 23
- 235000008599 Poria cocos Nutrition 0.000 claims abstract description 23
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 20
- 235000006886 Zingiber officinale Nutrition 0.000 claims abstract description 19
- 239000000284 extract Substances 0.000 claims abstract description 19
- 235000008397 ginger Nutrition 0.000 claims abstract description 19
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 claims abstract description 15
- 210000003038 endothelium Anatomy 0.000 claims abstract description 15
- 235000006140 Raphanus sativus var sativus Nutrition 0.000 claims abstract description 14
- 235000006533 astragalus Nutrition 0.000 claims abstract description 12
- 235000002722 Dioscorea batatas Nutrition 0.000 claims abstract description 11
- 235000006536 Dioscorea esculenta Nutrition 0.000 claims abstract description 11
- 240000001811 Dioscorea oppositifolia Species 0.000 claims abstract description 11
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 claims abstract description 11
- 235000010580 Psophocarpus tetragonolobus Nutrition 0.000 claims abstract description 11
- 241000046198 Triteleia hyacinthina Species 0.000 claims abstract description 11
- 235000013325 dietary fiber Nutrition 0.000 claims abstract description 11
- 239000012153 distilled water Substances 0.000 claims abstract description 11
- 235000003599 food sweetener Nutrition 0.000 claims abstract description 11
- 239000002904 solvent Substances 0.000 claims abstract description 11
- 239000003381 stabilizer Substances 0.000 claims abstract description 11
- 239000003765 sweetening agent Substances 0.000 claims abstract description 11
- 244000119298 Emblica officinalis Species 0.000 claims abstract description 10
- 235000015489 Emblica officinalis Nutrition 0.000 claims abstract description 10
- 240000006927 Foeniculum vulgare Species 0.000 claims abstract description 10
- 235000004204 Foeniculum vulgare Nutrition 0.000 claims abstract description 10
- 235000003145 Hippophae rhamnoides Nutrition 0.000 claims abstract description 10
- 241000045403 Astragalus propinquus Species 0.000 claims abstract description 9
- 241000167854 Bourreria succulenta Species 0.000 claims abstract description 9
- 240000003915 Lophatherum gracile Species 0.000 claims abstract description 9
- 241000612118 Samolus valerandi Species 0.000 claims abstract description 9
- 244000273928 Zingiber officinale Species 0.000 claims abstract description 9
- 235000019693 cherries Nutrition 0.000 claims abstract description 9
- 235000003332 Ilex aquifolium Nutrition 0.000 claims abstract description 8
- 235000002296 Ilex sandwicensis Nutrition 0.000 claims abstract description 8
- 235000002294 Ilex volkensiana Nutrition 0.000 claims abstract description 8
- 238000000034 method Methods 0.000 claims abstract description 8
- 240000000950 Hippophae rhamnoides Species 0.000 claims abstract description 5
- 244000088415 Raphanus sativus Species 0.000 claims abstract 5
- 241000218236 Cannabis Species 0.000 claims description 14
- 235000013399 edible fruits Nutrition 0.000 claims description 13
- 241000229143 Hippophae Species 0.000 claims description 11
- 239000007788 liquid Substances 0.000 claims description 10
- 230000001954 sterilising effect Effects 0.000 claims description 10
- 239000000243 solution Substances 0.000 claims description 8
- 235000003935 Hippophae Nutrition 0.000 claims description 6
- 239000002253 acid Substances 0.000 claims description 6
- 238000001816 cooling Methods 0.000 claims description 6
- 108010059892 Cellulase Proteins 0.000 claims description 5
- 240000008669 Hedera helix Species 0.000 claims description 5
- 239000009636 Huang Qi Substances 0.000 claims description 5
- 229940106157 cellulase Drugs 0.000 claims description 5
- 238000005516 engineering process Methods 0.000 claims description 5
- 238000001914 filtration Methods 0.000 claims description 5
- 239000009609 fructus phyllanthi Substances 0.000 claims description 5
- 239000011259 mixed solution Substances 0.000 claims description 5
- 238000004806 packaging method and process Methods 0.000 claims description 5
- 239000000843 powder Substances 0.000 claims description 5
- 238000007873 sieving Methods 0.000 claims description 5
- 238000004659 sterilization and disinfection Methods 0.000 claims description 5
- 238000005303 weighing Methods 0.000 claims description 5
- 238000004519 manufacturing process Methods 0.000 claims description 3
- 241000411851 herbal medicine Species 0.000 claims 2
- 230000000694 effects Effects 0.000 abstract description 28
- 210000000952 spleen Anatomy 0.000 abstract description 22
- 230000001737 promoting effect Effects 0.000 abstract description 16
- 235000009508 confectionery Nutrition 0.000 abstract description 11
- 230000002496 gastric effect Effects 0.000 abstract description 8
- 230000000144 pharmacologic effect Effects 0.000 abstract description 8
- 229940079593 drug Drugs 0.000 abstract description 7
- 230000008569 process Effects 0.000 abstract description 6
- 238000012360 testing method Methods 0.000 abstract description 5
- 230000001976 improved effect Effects 0.000 abstract description 4
- 241001061264 Astragalus Species 0.000 abstract description 3
- 241000721047 Danaus plexippus Species 0.000 abstract description 3
- 239000000463 material Substances 0.000 abstract description 3
- 210000004233 talus Anatomy 0.000 abstract description 3
- 239000003205 fragrance Substances 0.000 abstract description 2
- 235000019614 sour taste Nutrition 0.000 abstract description 2
- 230000002195 synergetic effect Effects 0.000 abstract description 2
- 240000004308 marijuana Species 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 description 20
- 239000008280 blood Substances 0.000 description 20
- 230000006870 function Effects 0.000 description 18
- 210000002784 stomach Anatomy 0.000 description 17
- 244000077995 Coix lacryma jobi Species 0.000 description 16
- 230000001603 reducing effect Effects 0.000 description 15
- 241000234314 Zingiber Species 0.000 description 10
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 10
- 241000220259 Raphanus Species 0.000 description 9
- 230000002401 inhibitory effect Effects 0.000 description 9
- 230000007812 deficiency Effects 0.000 description 8
- 230000029087 digestion Effects 0.000 description 8
- 201000001320 Atherosclerosis Diseases 0.000 description 7
- 206010012735 Diarrhoea Diseases 0.000 description 7
- 210000004072 lung Anatomy 0.000 description 7
- 206010011224 Cough Diseases 0.000 description 6
- 235000001188 Peltandra virginica Nutrition 0.000 description 6
- 230000009471 action Effects 0.000 description 6
- 208000010643 digestive system disease Diseases 0.000 description 6
- 230000001965 increasing effect Effects 0.000 description 6
- 210000003734 kidney Anatomy 0.000 description 6
- 210000004185 liver Anatomy 0.000 description 6
- 235000000346 sugar Nutrition 0.000 description 6
- 206010061218 Inflammation Diseases 0.000 description 5
- 238000002575 gastroscopy Methods 0.000 description 5
- 210000002216 heart Anatomy 0.000 description 5
- 230000004054 inflammatory process Effects 0.000 description 5
- 230000003405 preventing effect Effects 0.000 description 5
- 230000001105 regulatory effect Effects 0.000 description 5
- 238000011160 research Methods 0.000 description 5
- 235000015112 vegetable and seed oil Nutrition 0.000 description 5
- 238000010792 warming Methods 0.000 description 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- 206010010774 Constipation Diseases 0.000 description 4
- 241000196324 Embryophyta Species 0.000 description 4
- 206010062717 Increased upper airway secretion Diseases 0.000 description 4
- 208000002193 Pain Diseases 0.000 description 4
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 4
- 230000032683 aging Effects 0.000 description 4
- 230000036528 appetite Effects 0.000 description 4
- 235000019789 appetite Nutrition 0.000 description 4
- 230000002526 effect on cardiovascular system Effects 0.000 description 4
- 229930003944 flavone Natural products 0.000 description 4
- 150000002212 flavone derivatives Chemical class 0.000 description 4
- 235000011949 flavones Nutrition 0.000 description 4
- 239000012530 fluid Substances 0.000 description 4
- 150000004676 glycans Chemical class 0.000 description 4
- 230000006872 improvement Effects 0.000 description 4
- 230000005764 inhibitory process Effects 0.000 description 4
- 230000027939 micturition Effects 0.000 description 4
- 230000007935 neutral effect Effects 0.000 description 4
- 208000026435 phlegm Diseases 0.000 description 4
- 229920001282 polysaccharide Polymers 0.000 description 4
- 239000005017 polysaccharide Substances 0.000 description 4
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 4
- 208000004998 Abdominal Pain Diseases 0.000 description 3
- 244000037364 Cinnamomum aromaticum Species 0.000 description 3
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 description 3
- 208000007882 Gastritis Diseases 0.000 description 3
- 208000032843 Hemorrhage Diseases 0.000 description 3
- 108010028554 LDL Cholesterol Proteins 0.000 description 3
- 208000004880 Polyuria Diseases 0.000 description 3
- 208000025865 Ulcer Diseases 0.000 description 3
- 208000019790 abdominal distention Diseases 0.000 description 3
- 230000000740 bleeding effect Effects 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 235000012000 cholesterol Nutrition 0.000 description 3
- 206010012601 diabetes mellitus Diseases 0.000 description 3
- 230000035619 diuresis Effects 0.000 description 3
- 208000000718 duodenal ulcer Diseases 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 210000000936 intestine Anatomy 0.000 description 3
- 210000002429 large intestine Anatomy 0.000 description 3
- 208000031225 myocardial ischemia Diseases 0.000 description 3
- 210000004165 myocardium Anatomy 0.000 description 3
- 210000000813 small intestine Anatomy 0.000 description 3
- 235000019640 taste Nutrition 0.000 description 3
- 231100000397 ulcer Toxicity 0.000 description 3
- UCTWMZQNUQWSLP-VIFPVBQESA-N (R)-adrenaline Chemical compound CNC[C@H](O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-VIFPVBQESA-N 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- 206010000060 Abdominal distension Diseases 0.000 description 2
- 101710095342 Apolipoprotein B Proteins 0.000 description 2
- 102100040202 Apolipoprotein B-100 Human genes 0.000 description 2
- 206010003694 Atrophy Diseases 0.000 description 2
- 241000193830 Bacillus <bacterium> Species 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 208000024172 Cardiovascular disease Diseases 0.000 description 2
- MKMCJLMBVKHUMS-UHFFFAOYSA-N Coixol Chemical compound COC1=CC=C2NC(=O)OC2=C1 MKMCJLMBVKHUMS-UHFFFAOYSA-N 0.000 description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- 108010023302 HDL Cholesterol Proteins 0.000 description 2
- 206010019233 Headaches Diseases 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 206010067171 Regurgitation Diseases 0.000 description 2
- 241000191967 Staphylococcus aureus Species 0.000 description 2
- 208000007107 Stomach Ulcer Diseases 0.000 description 2
- 208000033809 Suppuration Diseases 0.000 description 2
- 210000001744 T-lymphocyte Anatomy 0.000 description 2
- 208000037386 Typhoid Diseases 0.000 description 2
- 229930003268 Vitamin C Natural products 0.000 description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 208000022531 anorexia Diseases 0.000 description 2
- 230000002929 anti-fatigue Effects 0.000 description 2
- 206010003549 asthenia Diseases 0.000 description 2
- 229940107666 astragalus root Drugs 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 230000037444 atrophy Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 230000007969 cellular immunity Effects 0.000 description 2
- 208000026106 cerebrovascular disease Diseases 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 206010061428 decreased appetite Diseases 0.000 description 2
- 230000003467 diminishing effect Effects 0.000 description 2
- 208000001848 dysentery Diseases 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 208000023062 epigastric abdominal pain Diseases 0.000 description 2
- 230000004438 eyesight Effects 0.000 description 2
- 210000001156 gastric mucosa Anatomy 0.000 description 2
- 201000005917 gastric ulcer Diseases 0.000 description 2
- 210000001035 gastrointestinal tract Anatomy 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- 230000004727 humoral immunity Effects 0.000 description 2
- 239000000413 hydrolysate Substances 0.000 description 2
- 230000036737 immune function Effects 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 230000000302 ischemic effect Effects 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 210000002540 macrophage Anatomy 0.000 description 2
- 230000002107 myocardial effect Effects 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 230000036284 oxygen consumption Effects 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 150000003254 radicals Chemical class 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 210000002460 smooth muscle Anatomy 0.000 description 2
- 230000004936 stimulating effect Effects 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- 230000002936 tranquilizing effect Effects 0.000 description 2
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 2
- 201000008297 typhoid fever Diseases 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 235000019154 vitamin C Nutrition 0.000 description 2
- 239000011718 vitamin C Substances 0.000 description 2
- 229930182837 (R)-adrenaline Natural products 0.000 description 1
- 108010051913 15-hydroxyprostaglandin dehydrogenase Proteins 0.000 description 1
- 102100030489 15-hydroxyprostaglandin dehydrogenase [NAD(+)] Human genes 0.000 description 1
- 206010000234 Abortion spontaneous Diseases 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- 241001127714 Amomum Species 0.000 description 1
- 206010002482 Angiosclerosis Diseases 0.000 description 1
- 108010071619 Apolipoproteins Proteins 0.000 description 1
- 102000007592 Apolipoproteins Human genes 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 241001480043 Arthrodermataceae Species 0.000 description 1
- 241000194107 Bacillus megaterium Species 0.000 description 1
- 102000004506 Blood Proteins Human genes 0.000 description 1
- 108010017384 Blood Proteins Proteins 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 208000005623 Carcinogenesis Diseases 0.000 description 1
- 206010007882 Cellulitis Diseases 0.000 description 1
- 208000027932 Collagen disease Diseases 0.000 description 1
- 206010009944 Colon cancer Diseases 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- 235000019750 Crude protein Nutrition 0.000 description 1
- 208000008967 Enuresis Diseases 0.000 description 1
- 206010015137 Eructation Diseases 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 206010016807 Fluid retention Diseases 0.000 description 1
- 208000036119 Frailty Diseases 0.000 description 1
- 208000018522 Gastrointestinal disease Diseases 0.000 description 1
- 208000012671 Gastrointestinal haemorrhages Diseases 0.000 description 1
- 206010018367 Glomerulonephritis chronic Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 208000005100 Herpetic Keratitis Diseases 0.000 description 1
- 206010020601 Hyperchlorhydria Diseases 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 208000008839 Kidney Neoplasms Diseases 0.000 description 1
- 241000629412 Ligustrum robustum Species 0.000 description 1
- 102000004882 Lipase Human genes 0.000 description 1
- 108090001060 Lipase Proteins 0.000 description 1
- 239000004367 Lipase Substances 0.000 description 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 208000001894 Nasopharyngeal Neoplasms Diseases 0.000 description 1
- 206010061306 Nasopharyngeal cancer Diseases 0.000 description 1
- 206010073938 Ophthalmic herpes simplex Diseases 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 240000004371 Panax ginseng Species 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 206010061902 Pancreatic neoplasm Diseases 0.000 description 1
- 102000057297 Pepsin A Human genes 0.000 description 1
- 108090000284 Pepsin A Proteins 0.000 description 1
- 206010057249 Phagocytosis Diseases 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 1
- 235000011613 Pinus brutia Nutrition 0.000 description 1
- 241000018646 Pinus brutia Species 0.000 description 1
- 241001619461 Poria <basidiomycete fungus> Species 0.000 description 1
- 241000588769 Proteus <enterobacteria> Species 0.000 description 1
- 235000003487 Prunus besseyi Nutrition 0.000 description 1
- 235000005805 Prunus cerasus Nutrition 0.000 description 1
- 235000015521 Prunus fruticosa Nutrition 0.000 description 1
- 240000003462 Prunus pumila Species 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 206010038084 Rectocele Diseases 0.000 description 1
- 206010038389 Renal cancer Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 240000005499 Sasa Species 0.000 description 1
- 206010039710 Scleroderma Diseases 0.000 description 1
- 241000607768 Shigella Species 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- 208000005718 Stomach Neoplasms Diseases 0.000 description 1
- 201000002014 Suppurative Otitis Media Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 238000009098 adjuvant therapy Methods 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 229960000458 allantoin Drugs 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000001775 anti-pathogenic effect Effects 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 230000000767 anti-ulcer Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 208000002399 aphthous stomatitis Diseases 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 210000003719 b-lymphocyte Anatomy 0.000 description 1
- 230000003385 bacteriostatic effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 229940076810 beta sitosterol Drugs 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 description 1
- NJKOMDUNNDKEAI-UHFFFAOYSA-N beta-sitosterol Natural products CCC(CCC(C)C1CCC2(C)C3CC=C4CC(O)CCC4C3CCC12C)C(C)C NJKOMDUNNDKEAI-UHFFFAOYSA-N 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 230000036952 cancer formation Effects 0.000 description 1
- 235000014171 carbonated beverage Nutrition 0.000 description 1
- 231100000504 carcinogenesis Toxicity 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- 208000019902 chronic diarrheal disease Diseases 0.000 description 1
- 208000023652 chronic gastritis Diseases 0.000 description 1
- 208000029742 colonic neoplasm Diseases 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 230000037304 dermatophytes Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 235000004879 dioscorea Nutrition 0.000 description 1
- 206010013023 diphtheria Diseases 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 206010013781 dry mouth Diseases 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 235000018927 edible plant Nutrition 0.000 description 1
- 230000009982 effect on human Effects 0.000 description 1
- 229960005139 epinephrine Drugs 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- -1 flavonoid compounds Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 210000002683 foot Anatomy 0.000 description 1
- 244000053095 fungal pathogen Species 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 210000004211 gastric acid Anatomy 0.000 description 1
- 206010017758 gastric cancer Diseases 0.000 description 1
- 230000005176 gastrointestinal motility Effects 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 235000001727 glucose Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 210000003494 hepatocyte Anatomy 0.000 description 1
- 230000002443 hepatoprotective effect Effects 0.000 description 1
- 235000012171 hot beverage Nutrition 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000007365 immunoregulation Effects 0.000 description 1
- 230000004377 improving vision Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 201000010982 kidney cancer Diseases 0.000 description 1
- 235000019421 lipase Nutrition 0.000 description 1
- 230000003859 lipid peroxidation Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 108010022197 lipoprotein cholesterol Proteins 0.000 description 1
- 201000007270 liver cancer Diseases 0.000 description 1
- 208000014018 liver neoplasm Diseases 0.000 description 1
- 230000001050 lubricating effect Effects 0.000 description 1
- 201000005202 lung cancer Diseases 0.000 description 1
- 208000020816 lung neoplasm Diseases 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 208000015486 malignant pancreatic neoplasm Diseases 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 208000015994 miscarriage Diseases 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 230000001151 other effect Effects 0.000 description 1
- 230000000242 pagocytic effect Effects 0.000 description 1
- 201000002528 pancreatic cancer Diseases 0.000 description 1
- 208000008443 pancreatic carcinoma Diseases 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 229940111202 pepsin Drugs 0.000 description 1
- 210000003819 peripheral blood mononuclear cell Anatomy 0.000 description 1
- 238000005502 peroxidation Methods 0.000 description 1
- 230000008782 phagocytosis Effects 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 206010036067 polydipsia Diseases 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 230000002633 protecting effect Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 230000013777 protein digestion Effects 0.000 description 1
- 201000001474 proteinuria Diseases 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 230000004223 radioprotective effect Effects 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 210000004994 reproductive system Anatomy 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 206010039073 rheumatoid arthritis Diseases 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 1
- 229950005143 sitosterol Drugs 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 230000001148 spastic effect Effects 0.000 description 1
- 208000000995 spontaneous abortion Diseases 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 201000011549 stomach cancer Diseases 0.000 description 1
- 208000018556 stomach disease Diseases 0.000 description 1
- 230000004206 stomach function Effects 0.000 description 1
- 210000004003 subcutaneous fat Anatomy 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 235000019605 sweet taste sensations Nutrition 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 210000001541 thymus gland Anatomy 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 230000010415 tropism Effects 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 210000004916 vomit Anatomy 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/38—Other non-alcoholic beverages
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/42—Preservation of non-alcoholic beverages
- A23L2/46—Preservation of non-alcoholic beverages by heating
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
- A23L2/60—Sweeteners
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/70—Clarifying or fining of non-alcoholic beverages; Removing unwanted matter
- A23L2/84—Clarifying or fining of non-alcoholic beverages; Removing unwanted matter using microorganisms or biological material, e.g. enzymes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L5/00—Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
- A23L5/30—Physical treatment, e.g. electrical or magnetic means, wave energy or irradiation
- A23L5/32—Physical treatment, e.g. electrical or magnetic means, wave energy or irradiation using phonon wave energy, e.g. sound or ultrasonic waves
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/57—Birds; Materials from birds, e.g. eggs, feathers, egg white, egg yolk or endothelium corneum gigeriae galli
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/235—Foeniculum (fennel)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/47—Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/482—Cassia, e.g. golden shower tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/734—Crataegus (hawthorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/894—Dioscoreaceae (Yam family)
- A61K36/8945—Dioscorea, e.g. yam, Chinese yam or water yam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8969—Polygonatum (Solomon's seal)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
- A61K36/8994—Coix (Job's tears)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
- A61K36/8998—Hordeum (barley)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9064—Amomum, e.g. round cardamom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9068—Zingiber, e.g. garden ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/10—Preparation or pretreatment of starting material
- A61K2236/19—Preparation or pretreatment of starting material involving fermentation using yeast, bacteria or both; enzymatic treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Mycology (AREA)
- Botany (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
一种用于改善人体消化系统的本草饮料及其制作方式,包括以下组分:中药提取成分、膳食纤维、甜味剂、增溶剂、稳定剂,余量为蒸馏水;其中,中药提取成分包括:茯苓、莱菔子、黄芪、山楂、薏苡仁、麦芽、鸡内金、干姜、火麻仁、郁李仁、生姜、余甘子、决明子、淡竹叶、山药、黄精、沙棘、砂仁、白扁豆、小茴香、苦丁茶;本发明提供的本草饮料,工艺简单,易于操作,成本低,采用茯苓为君药,遣方采用黄芪、莱菔子、麦芽等成分,改善胃肠推进功能,在众多成分的协同作用下实现升提阳气,补气健脾之功效,通过配伍药材,使饮料略伴有茯苓和麦芽的香味,且带有山楂的甜酸味,经药理试验证实,有效率达到96%。
Description
技术领域
本发明涉及保健饮料制备技术领域,尤其涉及一种用于改善人体消化系统的本草饮料及其制作方式。
背景技术
随着中国消费者健康意识的不断增强,中国人对养生的需求也逐渐提高,同样,近年来在生活节奏加快、工作和生活压力增加等多种因素的作用下,消化系统疾病的患病率逐年上升;而随着年龄的增加、人口结构老化,胃肠道疾病等消化系统疾病发病率也越来越高。同时,因消化系统疾病存在着高复发率的特征,大部分患者将在很长的一段时间内需连续用药。因此在患者增多以及消化系统疾病一般需长期服药这两大因素的推动下,消化系统疾病用药需求持续增长,长期服药会对肝肾系统带来不同程度地毒副作用,食疗法是通过食物滋补达到对胃肠道的调节,但食物一般属性味平和,调节效果不显著,而且因人而异,调节效果会各有差异,不具有普适性;
近年来,非碳酸饮料、尤其是以药食同源植物为原料的植物饮料受到消费者的青睐,但目前市面上的植物饮料含糖量较高或入口较苦,导致口感较差,而且有益成分不明确,因此,开发一种可以改善人体消化系统、安全、可长期服用的本草饮料成为本领域研究人员的研究热点,具有极大的研发意义。
发明内容
本发明要解决的技术问题是克服现有的缺陷,提供了一种用于改善人体消化系统的本草饮料,按质量百分比计,包括以下组分:中药提取成分10-13%、膳食纤维3-6%、甜味剂0.1-0.4%、增溶剂0.05-0.15%、稳定剂0.05-0.15%,余量为蒸馏水;
其中,所述的中药提取成分按重量份计包括:茯苓10-15份、莱菔子8-12份、黄芪6-10份、山楂5-10份、薏苡仁5-9份、麦芽4-8份、鸡内金3-5份、干姜3-5份、火麻仁2-5份、郁李仁2-4份、生姜1-3.5份、余甘子1-3份、决明子1-3份、淡竹叶1-3份、山药1-2份、黄精1-2份、沙棘1-2份、砂仁1-2份、白扁豆0.5-1份、小茴香1-2份、苦丁茶0.5-1份。
进一步地,所述的中药提取成分按重量份计包括:茯苓10-13份、莱菔子10-12份、黄芪6-8份、山楂5-8份、薏苡仁5-8份、麦芽6-8份、鸡内金4-5份、干姜3-4份、火麻仁3-5份、郁李仁3-4份、生姜1.5-3.5份、余甘子2-3份、决明子2-3份、淡竹叶2-3份、山药1-1.5份、黄精1.5-2份、沙棘1.5-2份、砂仁1.5-2份、白扁豆0.5-0.8份、小茴香1.5-2份、苦丁茶0.5-0.6份。
本发明基于传统医学理论,筛选出天然植物和药物,按照中医理论配方制成;
茯苓:又称松茯苓,为中药的“四君八珍”之一,具有利水渗湿,健脾补中,宁心安神等功能,现代药理研究表明茯苓有以下作用:(1)免疫调节能力,能激活淋巴T细胞和B细胞,抗胸腺萎缩,抗脾脏增大,增强巨噬细胞吞噬能力等作用;(2)辅助抑制肿瘤;(3)延缓衰老作用,有抑制自由基过氧化反应,降低脂质过氧化作用,减少脂褐质形成,故有延缓机体衰老的功能;(4)茯苓的煎液有镇静、利尿、强壮等作用,防止肝细胞坏死的功效。
莱菔子:莱菔子味辛、性寒,甘,平,归脾、胃、肺经,具有消食除胀,降气化痰,滑肠的功效;用于饮食停滞,脘腹胀痛,大便秘结,积滞泻痢,痰壅喘咳。
黄芪:又称为小人参,为多年生草本,味甘,性微温;归脾、肺经,功能主治:补中益气,利尿托毒,排脓,敛疮生肌。用于气虚乏力,食少便溏,中气下陷,久泻脱肛,便血崩漏,表虚自汗,气虚水肿,痈疽难溃,久溃不敛,血虚痿黄,内热消渴;慢性肾炎蛋白尿,糖尿病。黄芪味甘,气微温,气薄而味浓,可升可降,阳中之阳也,无毒。专补气,入手太阴、足太阴、手少阴之经,其功用甚多,而其独效者,尤在补血。
山楂:又名山里红,红果,富含碳水化合物、维生素、有机酸、矿物质和黄酮类化合物,可药果兼用,具有消食健胃,行气散瘀,化浊降脂的作用;药理作用:(1)助消化:山楂含多种有机酸,口服后增强胃液酸度,提高胃蛋白酶活性,促进蛋白质的消化;山楂味酸,刺激胃黏膜促进胃液分泌;山楂中含脂肪酶,能促进脂肪的消化;山楂含有维生素C等成分,口服可增进食欲;山楂对胃肠运动功能具有调节作用,对痉挛状态的胃肠平滑肌有抑制作用,对松弛状态的平滑肌有兴奋作用;(2)降血脂、抗动脉粥样硬化:山楂黄酮可显著降低实验性高血脂动物的血清总胆固醇(TC)、低密度脂蛋白胆固醇(LDL-C)和载脂蛋白B(ApoB)的浓度,显著升高高密度脂蛋白一胆固醇(HDL-C)和载脂蛋白A(ApoA)浓度,但对甘油三酯(TG)影响不大。山楂降血脂作用是通过抑制肝脏胆固醇的合成,促进肝脏对血浆胆固醇的摄人而发挥降血脂作用。山楂黄酮还可降低动脉粥样硬化(AS)发生的危险性,起到预防AS发生发展的作用;(3)对心血管系统的作用,抗心肌缺血:山楂对急性实验性心肌缺血具有保护作用,山楂黄酮、水解产物增加缺血心肌营养性血流量,其中以山楂水解产物作用最强,山楂在增加冠状动脉血流量的同时,还能降低心肌耗氧量,提高氧利用率;山楂黄酮具有改善动物的缺血心电图作用;(4)抑菌:山楂对志贺菌属、变形杆菌、大肠埃希菌、金黄色葡萄球菌等有较强的抑菌作用。
薏苡仁:有利水渗透湿,健脾止泻,除痹,排脓,解毒散结。药理作用:(1)抗肿瘤,现已证实,薏仁中的薏仁油、薏仁酯(coixenolide,CXL)等成分有抗肿瘤作用,如抑制癌细胞转移和增生、诱导癌细胞凋亡、抑制肿瘤血管形成且能提高放射时的敏感性等,已广泛用于临床的抗肿瘤药物,其主要成分为薏仁油,它对肝癌、胃癌、结肠癌、肺癌、胰腺癌、鼻咽癌、肾癌等都有良好的治疗或辅助治疗作用;(2)薏仁免疫调节,研究表明,薏仁酯和薏仁多糖能显著促进健康人末梢血单核细胞产生抗体,促进淋巴细胞转化,增强体液免疫和细胞免疫。薏仁油和薏仁多糖均可增强T细胞的免疫功能,具有一定的抗衰老作用;(3)薏仁降糖降脂,薏仁中含羟基的不饱和脂肪酸和多糖具有降糖降脂作用,为中医临床治疗糖尿病及其并发症、心脑血管疾病等的常用药物;薏仁油能降低密度脂蛋白胆固醇水平、能降低血清中胆固醇和低密度脂蛋白胆固醇浓度,并能通过清除自由基和活性氧提高机体的总抗氧化能力,证明薏仁提取物可用于预防和治疗动脉粥样硬化和冠心病等心脑血管疾病;(4)薏仁消炎镇痛止血,薏仁中的薏苡素、β-谷甾醇等具有镇痛消炎止血的作用;(5)薏仁其他还有抑制骨质疏松、缓解疲劳、调节生殖系统、治疗皮肤疾病等作用。
麦芽:归脾、胃经,有健脾开胃、行气消食的功效,尤其擅长促进淀粉类食物的消化,适用于脘腹胀满、反酸嗳气、不思饮食等症。
鸡内金:性甘,平,归脾、胃、小肠、膀胱经,健胃消食,涩精止遗,通淋化石。
干姜:味辛,性热,归脾、胃、肾、心、肺经,用于治脾胃虚寒,腹痛下利,以及胃中寒饮,喜唾涎沫,主治脘腹冷痛、呕吐、泄泻等。
火麻仁:甘,平。归脾、胃、大肠经。润肠通便,用于血虚津亏,肠燥便。
郁李仁:辛、苦、甘、平,归脾、大肠、小肠经,润肠通便、下气、利水消肿。
生姜:性味辛温,具有发汗解表、温中止呕、温肺止咳、解鱼蟹毒、解药毒的功效。可适用于外感风寒、头痛、痰饮、咳嗽、胃寒呕吐,在遭受寒冷侵袭后,辅之以热饮可增进血行、驱散寒邪。
余甘子:清热凉血,消食健胃,生津止咳;可适用于血热血瘀,消化不良.腹胀,咳嗽,喉痛,口干。
决明子:味苦、甘、咸,性微寒,入肝、肾、大肠经;决明子还含有多种维生素和丰富的氨基酸、碳水化合物等,以种子供药用,具有清肝明目、润肠通便、降脂瘦身、抗菌消炎的功能,而且具有治疗便秘及高血脂、高血压的功效;现代药理研究表明决明子有以下作用:具有抗菌、预防动脉粥样硬化、抗血小板凝集的作用;抑制细胞免疫功能,对体液免疫功能无影响,可增强巨噬细胞吞服噬功能;保肝;泻下;促进胃液分泌;抑制15-羟基前列腺素脱氢酶的作用;毒性:致癌及有生殖毒性。其水浸液有降压、利尿作用,并有缓泻、收缩子宫作用;其醇浸出液对葡萄球菌及白喉、巨大芽孢、伤寒、副伤寒、乙型副伤寒、大肠等杆菌均有抑制作用;其水浸剂对多种致病性皮肤真菌均有抑制作用,并有降血脂的作用。
淡竹叶:性味甘、淡,寒;归经:归心、胃、小肠经;主治清心火,除烦热,利小便;用于消痰止渴,除上焦火,明眼目,利小便,治白浊,退热,散痔疮毒。
山药:健脾,补肺,固肾,益精。山药作为高营养食品含有大量蛋白质、糖类、B族维生素、维生素C、维生素E、葡萄糖、粗蛋白氨基酸、胆汁碱、尿囊素、及碘、钙、铁、磷等人体不可缺少的无机盐和微量元素等营养成分。现代科学分析,山药的最大特点是含有大量的黏蛋白。黏蛋白是一种多糖蛋白质的混合物,对人体具有特殊的保健作用,能防止脂肪沉积在心血管上,保持血管弹性,阻止动脉粥样硬化过早发生;可减少皮下脂肪堆积;能防止结缔组织的萎缩,预防类风湿关节炎、硬皮病等胶原病的发生。
黄精:具有补气养阴,健脾,润肺益肾。药理作用:(1)抗病原微生物作用,体外试验表明,黄精水提出液(1:320)对伤寒杆菌、金黄色葡萄球菌、抗酸杆菌有抑制作用,2%黄精在沙氏培养基内对常见致病真菌有不同程度的抑制作用;(2)对血糖的影响,黄精浸膏对肾上腺素引起的血糖过高呈显着抑制作用。(3)抗疲劳作用。(4)抗氧化作用:黄精煎液使心肌脂褐质含量降低。(5)延缓衰老作用;(6)止血作用;(7)心血管作用,对心肌缺血有对抗作用;(8)抗病毒作用,单纯疱疹病毒性角膜炎均有治疗作用。
沙棘:甘、酸、温,归脾、胃、肺、心经。健脾消食,止咳祛痰,活血祛瘀。沙棘有健脾消食、改善心肌微循环,降低心肌耗氧量,抗血管硬化,抗炎等作用;可以抗疲劳、降血脂、抗辐射、抗溃疡、保肝及增强免疫功能。
砂仁:“四大南药”之一,有化湿开胃,温脾止泻,理气安胎的功效。
白扁豆:性甘,微温。归脾、胃经。现代药理研究表明白扁豆具有提高免疫功能、抗菌、抗病毒、抗肿瘤、抗氧化、降血糖、降低胆固醇等作用。
小茴香:味辛,性温,具有散寒止痛,温肾缩尿,理气和胃,祛湿利浊等作用。
苦丁茶:疏风清热,明目生津。风热头痛;齿痛;目赤;聤耳;口疮;热病烦渴;泄泻;痢疾。
上述诸药共奏补气温阳之效,具有健脾补虚,益气养胃的功效,进一步地,本发明提供了上述本草饮料的制作方式,具体包括如下步骤:
(1)按配方量称取茯苓、莱菔子、黄芪、山楂、薏苡仁、麦芽、鸡内金、干姜、火麻仁、郁李仁、生姜、余甘子、决明子、淡竹叶、山药、黄精、沙棘、砂仁、白扁豆、小茴香、苦丁茶,然后进行超微粉碎并过筛;
(2)在步骤(1)中得到的混合药粉中加入温水,并加入纤维素酶进行酶解40-60min,得到酶解混合液;
(3)按重量百分比计,在步骤(3)得到的酶解混合液分批次加入蒸馏水,进行煎煮,煎煮3-4次,每次煎煮时间50-80min,将每次煎煮液合并,将合并煎煮液过滤后浓缩,得浓缩液;
(4)在浓缩液中加入膳食纤维、甜味剂、增溶剂和稳定剂,调酸定容,采用超高温瞬时杀菌技术杀菌,冷却后灌装即得。
优选地,步骤(2)中酶解温度为40-50℃。
优选地,步骤(3)中煎煮过程进行的同时辅以超声波,超声波功率为150-200W。
有益效果:
本发明提供的本草饮料,原料来源丰富,工艺简单,易于操作,成本低,采用药食同源的茯苓、莱菔子、黄芪、山楂、薏苡仁、麦芽等成分,采用茯苓为君药,遣方采用黄芪、莱菔子、麦芽等成分,改善胃肠推进功能,在众多成分的协同作用下实现升提阳气,补气健脾之功效,通过配伍药材,使饮料略伴有茯苓和麦芽的香味,且带有山楂的甜酸味,经药理试验证实,本草饮料安全性高,能够健脾补虚,益气养胃,可用于慢性胃炎以及胃溃疡,十二指肠溃疡的治疗,有效率达到96%,同时克服了西药治疗带给胃肠道的刺激性作用,不增加胃肠道的负担,非常便于胃肠患者的吸收。
具体实施方式
下面将结合本发明实施例,对本发明实施例中的技术方案进行清楚、完整地描述,显然,所描述的实施例仅仅是本发明一部分实施例,而不是全部的实施例。基于本发明中的实施例,本领域普通技术人员在没有做出创造性劳动前提下所获得的所有其他实施例,都属于本发明保护的范围。
实施例1
一种用于改善人体消化系统的本草饮料,按质量百分比计,包括以下组分:中药提取成分13%、膳食纤维4%、甜味剂0.3%、增溶剂0.12%、稳定剂0.10%,余量为蒸馏水;
其中,所述的中药提取成分按重量份计,包括以下组分:茯苓13份、莱菔子10份、黄芪8份、山楂8份、薏苡仁6份、麦芽8份、鸡内金4份、干姜3.5份、火麻仁3份、郁李仁4份、生姜2.5份、余甘子2份、决明子2.5份、淡竹叶2.5份、山药1.5份、黄精2份、沙棘2份、砂仁1.5份、白扁豆0.8份、小茴香1.5份、苦丁茶0.5份。
上述本草饮料的制作方式,具体包括如下步骤:
(1)按配方量称取茯苓、莱菔子、黄芪、山楂、薏苡仁、麦芽、鸡内金、干姜、火麻仁、郁李仁、生姜、余甘子、决明子、淡竹叶、山药、黄精、沙棘、砂仁、白扁豆、小茴香、苦丁茶,然后进行超微粉碎并过筛;
(2)在步骤(1)中得到的混合药粉中加入温水,并加入纤维素酶进行酶解55min,酶解温度为50℃,得到酶解混合液;
(3)按重量百分比计,在步骤(3)得到的酶解混合液分批次加入蒸馏水,进行煎煮,煎煮3次,每次煎煮时间60min,煎煮过程进行的同时辅以超声波,超声波功率为150W,将每次煎煮液合并,将合并煎煮液过滤后浓缩,得浓缩液;
(4)在浓缩液中加入膳食纤维、甜味剂、增溶剂和稳定剂,调酸定容,采用超高温瞬时杀菌技术杀菌,冷却后灌装即得。
实施例2
一种用于改善人体消化系统的本草饮料,按质量百分比计,包括以下组分:中药提取成分10%、膳食纤维4%、甜味剂0.3%、增溶剂0.08%、稳定剂0.10%,余量为蒸馏水;
其中,所述的中药提取成分按重量份计,包括以下组分:茯苓12份、莱菔子10份、黄芪7份、山楂7份、薏苡仁6份、麦芽7份、鸡内金5份、干姜3份、火麻仁4份、郁李仁3份、生姜2.5份、余甘子2.5份、决明子2份、淡竹叶2份、山药1份、黄精2份、沙棘1.5份、砂仁2份、白扁豆0.6份、小茴香1.8份、苦丁茶0.6份。
上述本草饮料的制作方式,具体包括如下步骤:
(1)按配方量称取茯苓、莱菔子、黄芪、山楂、薏苡仁、麦芽、鸡内金、干姜、火麻仁、郁李仁、生姜、余甘子、决明子、淡竹叶、山药、黄精、沙棘、砂仁、白扁豆、小茴香、苦丁茶,然后进行超微粉碎并过筛;
(2)在步骤(1)中得到的混合药粉中加入温水,并加入纤维素酶进行酶解60min,酶解温度为45℃,得到酶解混合液;
(3)按重量百分比计,在步骤(3)得到的酶解混合液分批次加入蒸馏水,进行煎煮,煎煮4次,每次煎煮时间80min,煎煮过程进行的同时辅以超声波,超声波功率为180W,将每次煎煮液合并,将合并煎煮液过滤后浓缩,得浓缩液;
(4)在浓缩液中加入膳食纤维、甜味剂、增溶剂和稳定剂,调酸定容,采用超高温瞬时杀菌技术杀菌,冷却后灌装即得。
实施例3
一种用于改善人体消化系统的本草饮料,按质量百分比计,包括以下组分:中药提取成分12%、膳食纤维5%、甜味剂0.3%、增溶剂0.12%、稳定剂0.12%,余量为蒸馏水;
其中,所述的中药提取成分按重量份计,包括以下组分:茯苓15份、莱菔子10份、黄芪8份、山楂6份、薏苡仁7份、麦芽5份、鸡内金4份、干姜4份、火麻仁3份、郁李仁3份、生姜2.5份、余甘子2份、决明子2份、淡竹叶3份、山药2份、黄精2份、沙棘1.5份、砂仁1份、白扁豆0.8份、小茴香1.5份、苦丁茶0.8份。
上述本草饮料的制作方式,具体包括如下步骤:
(1)按配方量称取茯苓、莱菔子、黄芪、山楂、薏苡仁、麦芽、鸡内金、干姜、火麻仁、郁李仁、生姜、余甘子、决明子、淡竹叶、山药、黄精、沙棘、砂仁、白扁豆、小茴香、苦丁茶,然后进行超微粉碎并过筛;
(2)在步骤(1)中得到的混合药粉中加入温水,并加入纤维素酶进行酶解60min,酶解温度为50℃,得到酶解混合液;
(3)按重量百分比计,在步骤(3)得到的酶解混合液分批次加入蒸馏水,进行煎煮,煎煮4次,每次煎煮时间70min,煎煮过程进行的同时辅以超声波,超声波功率为200W,将每次煎煮液合并,将合并煎煮液过滤后浓缩,得浓缩液;
(4)在浓缩液中加入膳食纤维、甜味剂、增溶剂和稳定剂,调酸定容,采用超高温瞬时杀菌技术杀菌,冷却后灌装即得。
性能测试
1、稳定性及口感试验
实施例1-3及市售一款本草饮料,对其进行外观以及糖度测试,测试结果示于表1;
表1
2、临床实验
以胃部疾病为例,选取50例临床患者,其中男性35例,平均年龄45岁;女性25例,平均年龄42岁,胃镜检查胃体溃疡12例,胃窦溃疡8例、十二指肠溃疡15例,慢性浅表性胃炎15例,全部病例均为胃镜检查确诊,对该50例患者使用该本草饮料,每天2瓶(50ml/瓶),服用后行胃镜检查,两周后有32例患者出现改善迹象,服用一个月后又有8位患者出现改善迹象,前述32例患者已有明显改善,两个月后无改善迹象有2人,总有效率达到96%。
典型案例
刘××,女,某化工厂退休工人,54岁,患慢性浅表性胃炎1-2年,上腹部腹痛、腹胀、餐后有饱胀感,进食后加重,伴有胃泛酸、嗳气和胃部灼烧感,服用本发明产品2个月后,胃镜检查胃粘膜斑点状出血量下降,胃小凹已不明显,腹痛腹胀症状明显改善,食欲明显改善,体重明显增加,精力充沛。
眭××,男,某药企员工,36岁,患十二指肠溃疡2-3年,上腹部腹痛、胃酸分泌过多,偶有黑色粪便出现,体重有减轻,服用本发明产品2个月后,胃镜检查溃疡面缩小,炎症下降,黑便状况不再出现,体重恢复到病前水准。
尽管已经示出和描述了本发明的实施例,对于本领域的普通技术人员而言,可以理解在不脱离本发明的原理和精神的情况下可以对这些实施例进行多种变化、修改、替换和变型,本发明的范围由所附权利要求及其等同物限定。
Claims (6)
1.一种用于改善人体消化系统的本草饮料,其特征在于,按质量百分比计,包括以下组分:中药提取成分10-13%、膳食纤维3-6%、甜味剂0.1-0.4%、增溶剂0.05-0.15%、稳定剂0.05-0.15%,余量为蒸馏水;
其中,所述的中药提取成分按重量份计包括:茯苓10-15份、莱菔子8-12份、黄芪6-10份、山楂5-10份、薏苡仁5-9份、麦芽4-8份、鸡内金3-5份、干姜3-5份、火麻仁2-5份、郁李仁2-4份、生姜1-3.5份、余甘子1-3份、决明子1-3份、淡竹叶1-3份、山药1-2份、黄精1-2份、沙棘1-2份、砂仁1-2份、白扁豆0.5-1份、小茴香1-2份、苦丁茶0.5-1份。
2.根据权利要求1所述的一种用于改善人体消化系统的本草饮料,其特征在于,所述的中药提取成分按重量份计包括:茯苓10-13份、莱菔子10-12份、黄芪6-8份、山楂5-8份、薏苡仁5-8份、麦芽6-8份、鸡内金4-5份、干姜3-4份、火麻仁3-5份、郁李仁3-4份、生姜1.5-3.5份、余甘子2-3份、决明子2-3份、淡竹叶2-3份、山药1-1.5份、黄精1.5-2份、沙棘1.5-2份、砂仁1.5-2份、白扁豆0.5-0.8份、小茴香1.5-2份、苦丁茶0.5-0.6份。
3.根据权利要求1所述的一种用于改善人体消化系统的本草饮料,其特征在于,所述的中药提取成分按重量份计包括:茯苓13份、莱菔子10份、黄芪8份、山楂8份、薏苡仁6份、麦芽8份、鸡内金4份、干姜3.5份、火麻仁3份、郁李仁4份、生姜2.5份、余甘子2份、决明子2.5份、淡竹叶2.5份、山药1.5份、黄精2份、沙棘2份、砂仁1.5份、白扁豆0.8份、小茴香1.5份、苦丁茶0.5份。
4.如权利要求1-3所述的本草饮料的制作方式,其特征在于,具体包括如下步骤:
(1)按配方量称取茯苓、莱菔子、黄芪、山楂、薏苡仁、麦芽、鸡内金、干姜、火麻仁、郁李仁、生姜、余甘子、决明子、淡竹叶、山药、黄精、沙棘、砂仁、白扁豆、小茴香、苦丁茶,然后进行超微粉碎并过筛;
(2)在步骤(1)中得到的混合药粉中加入温水,并加入纤维素酶进行酶解40-60min,得到酶解混合液;
(3)按重量百分比计,在步骤(3)得到的酶解混合液分批次加入蒸馏水,进行煎煮,煎煮3-4次,每次煎煮时间50-80min,将每次煎煮液合并,将合并煎煮液过滤后浓缩,得浓缩液;
(4)在浓缩液中加入膳食纤维、甜味剂、增溶剂和稳定剂,调酸定容,采用超高温瞬时杀菌技术杀菌,冷却后灌装即得。
5.根据权利要求4所述的一种用于改善人体消化系统的本草饮料的制作方式,其特征在于,步骤(2)中酶解温度为40-50℃。
6.根据权利要求4所述的种用于改善人体消化系统的本草饮料的制作方式,其特征在于,步骤(3)中煎煮过程进行的同时辅以超声波,超声波功率为150-200W。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110383658.5A CN113080347A (zh) | 2021-04-09 | 2021-04-09 | 一种用于改善人体消化系统的本草饮料及其制作方式 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110383658.5A CN113080347A (zh) | 2021-04-09 | 2021-04-09 | 一种用于改善人体消化系统的本草饮料及其制作方式 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN113080347A true CN113080347A (zh) | 2021-07-09 |
Family
ID=76675890
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110383658.5A Withdrawn CN113080347A (zh) | 2021-04-09 | 2021-04-09 | 一种用于改善人体消化系统的本草饮料及其制作方式 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN113080347A (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113785948A (zh) * | 2021-09-14 | 2021-12-14 | 三原利华生物技术有限公司 | 一种益气生津、润肠通便的固体饮料及其制备方法 |
-
2021
- 2021-04-09 CN CN202110383658.5A patent/CN113080347A/zh not_active Withdrawn
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113785948A (zh) * | 2021-09-14 | 2021-12-14 | 三原利华生物技术有限公司 | 一种益气生津、润肠通便的固体饮料及其制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102511869B (zh) | 红枣生姜浓浆 | |
CN102511867B (zh) | 红枣阿胶枸杞浓浆及其生产工艺 | |
CN106937741A (zh) | 一种脱脂亚麻籽粉防癌抗癌健康减肥法及其制备方法 | |
WO2022143466A1 (zh) | 一种预防癌症药食同源植物中药组合物 | |
CN113080347A (zh) | 一种用于改善人体消化系统的本草饮料及其制作方式 | |
CN102511866A (zh) | 红枣阿胶浓浆及其生产工艺 | |
CN102511876B (zh) | 山楂红枣浓浆及其生产工艺 | |
CN104146241B (zh) | 一种补益通便保健组合物及制备方法 | |
CN109820123A (zh) | 一种改善微循环的植物饮品及其制备方法 | |
CN102524868A (zh) | 红枣秋梨枇杷浓浆 | |
CN107296267A (zh) | 一种中药复合养胃酵素及其制备方法 | |
CN113662068A (zh) | 一种桂杞姜甘茶配方及其制备方法 | |
CN102524869A (zh) | 红枣秋梨枸杞浓浆 | |
CN102511868A (zh) | 一种添加维生素的红枣阿胶浓浆 | |
CN108813500B (zh) | 具有补中益气、养血安神和调节人体机能的养生蜂蜜膏 | |
CN112294925A (zh) | 一种用于治疗痛风、胃病、便秘的药物及其制备方法 | |
CN105995971A (zh) | 一种促进糖尿病康复的营养流食及其制备方法 | |
CN110693931A (zh) | 一种养生牛蒡咀嚼片配方及其制备方法 | |
CN110679935A (zh) | 一种牛蒡人参精华膏及其制备方法 | |
CN109876053A (zh) | 一种祛痘消炎、清肝解毒的组方及其制法 | |
CN108783443A (zh) | 一种用于脏腑调理的片剂及其制备方法 | |
CN108967757A (zh) | 一种红枣生姜浓浆生产工艺 | |
CN113057273A (zh) | 一种本草饮料及其制作方式 | |
CN107090387A (zh) | 一种健脾祛湿蜂蜜保健酒的制备方法 | |
CN113100367A (zh) | 一种基于中药的保健饮品及其制作方式 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WW01 | Invention patent application withdrawn after publication | ||
WW01 | Invention patent application withdrawn after publication |
Application publication date: 20210709 |